Dammarane-type triterpene extracts of Panax notoginseng root ameliorates hyperglycemia and insulin sensitivity by enhancing glucose uptake in skeletal muscle

Kumiko Kitamura,Yusuke Takamura,Taku Iwamoto,Mitsuru Nomura,Hideaki Iwasaki,Motoyasu Ohdera,Michiaki Murakoshi,Keikichi Sugiyama,Kazuki Matsuyama,Yasuko Manabe,Nobuharu L Fujii,Tohru Fushiki
DOI: https://doi.org/10.1080/09168451.2016.1246173
2017-02-01
Abstract:Abstract Skeletal muscle is an important organ for controlling the development of type 2 diabetes. We discovered Panax notoginseng roots as a candidate to improve hyperglycemia through in vitro muscle cells screening test. Saponins are considered as the active ingredients of ginseng. However, in the body, saponins are converted to dammarane-type triterpenes, which may account for the anti-hyperglycemic activity. We developed a method for producing a dammarane-type triterpene extract (DTE) from Panax notoginseng roots and investigated the extract’s potential anti-hyperglycemic activity. We found that DTE had stronger suppressive activity on blood glucose levels than the saponin extract (SE) did in KK-Ay mice. Additionally, DTE improved oral glucose tolerance, insulin sensitivity, glucose uptake, and Akt phosphorylation in skeletal muscle. These results suggest that DTE is a promising agent for controlling hyperglycemia by enhancing glucose uptake in skeletal muscle.
What problem does this paper attempt to address?